Research

Total deaths recorded during the pandemic far exceed those attributed to COVID-19

For every two deaths attributed to COVID-19 in the U.S., a third American dies as a result of the pandemic, according to new data publishing Oct. 12 in the Journal of the American Medical Association.

The study, led by researchers at Virginia Commonwealth University, shows that deaths between March 1 and Aug. 1 increased 20% compared to previous years - maybe not surprising in a pandemic. But deaths attributed to COVID-19 only accounted for 67% of those deaths.

Researchers call for loss of smell to be recognized globally as a symptom of COVID-19

Four out of five people experiencing the recent loss of smell and/or taste tested positive for COVID-19 antibodies - and of those who tested positive, 40 percent did not have cough or fever, reports a new study in PLOS Medicine by Prof. Rachel Batterham at University College London and colleagues.

Researchers uncover clues for COVID-19 treatment

By examining preexisting research for other conditions, researchers at the University of Cincinnati have found a potential treatment that could be applied to COVID-19.

The findings, published in the Journal of Biological Chemistry, established that a lipid found in the human body could be used to prevent or treat infections with SARS-CoV-2, the virus that causes COVID-19.

Adequate levels of vitamin D reduces complications, death among COVID-19 patients

Hospitalized COVID-19 patients who were vitamin D sufficient, with a blood level of 25-hydroxyvitamin D of at least 30 ng/mL (a measure of vitamin D status), had a significant decreased risk for adverse clinical outcomes including becoming unconscious, hypoxia (body starved for oxygen) and death.

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

Ever since SARS-CoV-2 first appeared, researchers have been trying to understand whether sometimes the immune system does more harm than good during the acute phase of COVID-19. The latest study by researchers at La Jolla Institute for Immunology clearly argues in favor of the immune system.

Designed antiviral proteins inhibit SARS-CoV-2 in the lab

Computer-designed small proteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19.

In the experiments, the lead antiviral candidate, named LCB1, rivaled the best-known SARS-CoV-2 neutralizing antibodies in its protective actions. LCB1 is currently being evaluated in rodents.

Research & Development

Popular COVID-19 conspiracies linked to vaccine 'hesitancy'

Total deaths recorded during the pandemic far exceed those attributed to COVID-19

Researchers call for loss of smell to be recognized globally as a symptom of COVID-19

Researchers uncover clues for COVID-19 treatment

Adequate levels of vitamin D reduces complications, death among COVID-19 patients

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

Designed antiviral proteins inhibit SARS-CoV-2 in the lab

More Pharma News ...